Key Highlights

  • Silex Systems item 1: silex Systems' US uranium enrichment venture, Global Laser Enrichment (GLE), has locked in Cameco Corporation as the buyer for all future output from its planned Paducah Laser Enrichment Facility (PLEF) in Kentucky.
  • Silex Systems item 2: it is important to be precise about what this is.
  • Silex Systems item 3: it is a commercial commitment to buy future product, not a Supply contract for uranium that exists today.
  • Silex Systems item 4: pLEF has not been built, is not licensed to operate, and has produced no commercial material.

Silex Systems (ASX:SLX) is addressing the GLE offtake and proposed Paducah enrichment facility through its disclosed corporate and operating programme. For Silex Systems, the current position separates completed steps from conditional terms and identifies the matters that still require formal decisions or further evidence. That distinction matters for Silex Systems because an announced proposal, approval, forecast or operating milestone may remain subject to conditions before it changes the completed financial or operational position.

Company Business

Silex Systems' US uranium enrichment venture, Global Laser Enrichment (GLE), has locked in Cameco Corporation as the buyer for all future output from its planned Paducah Laser Enrichment Facility (PLEF) in Kentucky. GLE and Cameco signed an exclusive offtake agreement announced on 13 September 2026, under which Cameco has committed to purchase 100% of the facility's planned production of natural uranium, low-enriched uranium and high-assay low-enriched uranium (HALEU) for advanced reactors, once the plant is built and operating Silex Systems signs exclusive nuclear offtake deal with Cameco.

It is important to be precise about what this is. It is a commercial commitment to buy future product, not a supply contract for uranium that exists today. PLEF has not been built, is not licensed to operate, and has produced no commercial material. The deal removes one major uncertainty - who would buy the output - well before construction begins.

Who is GLE, and why does it matter that Cameco is the buyer

Current Position

GLE, not Silex Systems itself, is the contracting party. GLE is a US joint venture that holds the exclusive licence to commercialise Silex's laser-based uranium enrichment technology, branded SILEX. Silex owns 51% of GLE and Cameco, the Canadian uranium major, owns 49% - a split that has held since a 2021 restructuring lifted Cameco's stake from 24% Cameco Increases Interest in Global Laser Enrichment. Cameco also holds a call option, open until April 2028, to lift its stake by a further 26%, which would take it to 75% Silex Systems investor briefing, 25 February 2026.

That ownership structure is central to understanding the new agreement. Cameco is simultaneously GLE's minority owner and now its committed customer. As GLE's largest prospective buyer, Cameco has an obvious commercial interest in seeing the venture succeed - which is one reason the offtake matters to Silex's commercialisation case, alongside removing Market Risk from GLE's Business plan.

Sector Context

That structure ties GLE's future Revenue to prevailing market conditions rather than guaranteeing a set uranium price.

Separately from the offtake, Silex retains a perpetual Royalty of 7% to 12% on GLE's enrichment revenue, on top of its Equity stake - a structure the company has said could be worth roughly US$100 million a year at full-scale Paducah output, at the lower end of that royalty range and at current uranium pricing assumptions Silex Systems investor briefing, 25 February 2026. That royalty figure is Silex's own estimate, not an independently verified forecast, and depends on the plant reaching the scale assumed.

Risks to Consider

Silex Systems remains exposed to execution, timing, regulatory, funding and market uncertainties relevant to the GLE offtake and proposed Paducah enrichment facility. Conditional proposals, guidance, approvals and commissioning targets involving Silex Systems may change before they produce a completed transaction or operating outcome.

The technology and timeline: still years from commercial output

SILEX is a laser-based uranium enrichment process, positioned by its backers as more efficient than the centrifuge technology used by incumbent enrichers. GLE has been demonstrating the technology at a test loop facility rather than at commercial scale. In September 2025, GLE said it had completed a large-scale demonstration campaign it described as proving the process "can be commercially deployed," a milestone Silex has referred to internally as reaching Technology Readiness Level 6 (TRL-6) GLE completes landmark laser technology demonstration.

What to Watch Next

The plan is for GLE to build PLEF on roughly 700 acres in Paducah, Kentucky, re-enriching around 200,000 tonnes of depleted uranium tailings left over from historical US government enrichment operations. However, the plant still requires a Nuclear Regulatory Commission operating licence, a final Investment decision, and construction - a process that will take years. Reporting on the offtake announcement places initial commercial operations as a 2030 target, which is itself contingent on funding, licensing and further technology validation.

On 6 January 2026, Silex told the ASX that GLE had missed out on a separate and much larger prize: a US Department of Energy Request for Proposals worth up to US$900 million to support domestic low-enriched uranium production. GLE was not selected for that award, though it was granted a smaller, roughly US$28 million DOE innovation grant to advance its laser enrichment technology DOE Funding Awards Outcomes.